Search NASA⌕ Search

Engineering topics

Micklich, B.

Publications and source records attributed to Micklich, B..

Irradiation of 20L LEU Uranyl Sulfate Solution for Production of Mo-99

Argonne National Laboratory, with support from the National Nuclear Security Administration’s Office of Material Management and Minimization, is assisting SHINE Medical Technologies in the development of accelerator-driven production of 99 Mo using low-enriched uranium (LEU). Technetium-99m ( 99m Tc), a daughter of 99 Mo, is a workhorse of nuclear medicine, used in approximately 40,000 medical testing procedures each day just in the U.S.

07 ISOTOPE AND RADIATION SOURCES↗

Production of Medical Isotopes with Electron Linacs

Radioisotopes play important roles in numerous areas ranging from medical treatments to national security and basic research. Radionuclide production technology for medical applications has been pursued since the early 1900s both commercially and in nuclear science centers. Many medical isotopes are now in routine production and are used in day-to-day medical procedures. Despite these advancements, research is accelerating around the world to improve the existing production methodologies as well as to develop novel radionuclides for new medical appli-cations. Electron linear accelerators (linacs) represent a unique method for the production of radioisotopes. Even though the basic technology has been around for decades, only recently have electron linacs capable of producing photons with sufficient energy and flux for radioisotope production become available. Housed in Argonne Nation-al Laboratory’s Low Energy Accelerator Facility (LEAF) is a newly upgraded 55 MeV/25-kW electron linear ac-celerator, capable of producing a wide range of radioiso-topes. This talk will focus on the work being performed for the production of the medical isotopes 99Mo (99Mo/99mTc generator), 67Cu, and 47Sc.

Cu-67↗

Setting a limit on anthropogenic sources of atmospheric 81 Kr through Atom Trap Trace Analysis

In this study, we place a 2.5% limit on the anthropogenic contribution to the modern abundance of 81 Kr/Kr in the atmosphere at the 90% confidence level. Due to its simple production and transport in the terrestrial environment, 81 Kr (half-life = 230,000 years) is an ideal tracer for old water and ice with mean residence times in the range of 105–106 years. In recent years, 81 Kr-dating has been made available to the earth science community thanks to the development of Atom Trap Trace Analysis (ATTA), a laser-based atom counting technique. Further upgrades and improvements to the ATTA technique now allow us to demonstrate 81 Kr/Kr measurements with relative uncertainties of 1% and place this new limit on anthropogenic 81 Kr. As a result of this limit, we have removed a potential systematic constraint for 81 Kr-dating.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Design of the Phase-2 Target for Mini-SHINE/MIPS Experiments

Under the National Nuclear Security Administration’s Global Threat Reduction Initiative (GTRI), Argonne National Laboratory (Argonne) is assisting three potential domestic producers to develop and implement molybdenum-99 (Mo-99) production in the United States without the use of highly enriched uranium (HEU). Two of the potential domestic producers are Babcock and Wilcox Technical Services Group (B&W) and Morgridge Institute for Research (MIR). B&W is developing the Medical Isotope Production System (MIPS). In this system, the Mo-99 is produced in an LEU-fueled Aqueous Homogenous Reactor (AHR) by the fissioning of uranium-235 (U-235). The MIPS consists of an AHR containing a low enriched uranium (LEU) solution, a molybdenum-extraction system utilizing a chromatographic column, and a reactor off-gas and solution-control systems. The use of AHRs presents an attractive alternative to the conventional target-irradiation method for producing Mo-99 because the fuel solution itself is used to produce Mo-99, eliminating the need for targets. AHRs also operate at a much lower power level than that required for a traditional reactor. The three areas of Argonne research and development (R&D) are (1) radiolytic-gas generation in the fuel solution, (2) effects of fission and radiation on reactor-solution chemistry, and (3) development and optimization recovery of molybdenum from the irradiated fuel solution.

Chemerisov, S.↗